Riociguat | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Riociguat
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

Contact Supplier

Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

Contact Supplier

Quotient Sciences- Molecule to Cure. Fast.

Contact Supplier

pharmacompass-2-m-2025-08-25

Riociguat

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

15 API Suppliers, 3 USDMF, 1 CEP/COS, 2 EU WC, 2 NDC API, 13 Listed Suppliers, $ API Reference Price

15 API Suppliers
3 USDMF
1 CEP/COS
2 EU WC
2 NDC API
13 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

31 Drugs in Development

31 Drugs in Development

FINISHED DOSAGE FORMULATIONS

76 FDF Dossiers, 14 FDA Orange Book, 32 Europe, 10 Canada, 20 Australia

76 FDF Dossiers
14 FDA Orange Book
32 Europe
10 Canada
20 Australia

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 4 DKSH, 3 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 BASF, 10 Corel Pharma Chem, 4 DFE Pharma, 1 Finar, 5 Gangwal Chemicals, 4 Ideal Cures, 19 Kerry, 1 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 9 Roquette, 6 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Sigachi Industries, 2 Silverline Chemicals, 2 The Dow Chemical Company, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

41 Coating Systems & Additives, 30 Fillers, Diluents & Binders, 16 Granulation, 15 Controlled & Modified Release, 14 Direct Compression, 12 Thickeners and Stabilizers, 11 Lubricants & Glidants, 8 Film Formers & Plasticizers, 8 Co-Processed Excipients, 6 Taste Masking, 5 Disintegrants & Superdisintegrants, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Coloring Agents, 4 Topical, 4 Rheology Modifiers, 4 Chewable & Orodispersible Aids, 3 API Stability Enhancers, 3 Solubilizers, 3 Emulsifying Agents, 2 Parenteral, 1 Surfactant & Foaming Agents

41 Coating Systems & Additives
30 Fillers, Diluents & Binders
16 Granulation
15 Controlled & Modified Release
14 Direct Compression
12 Thickeners and Stabilizers
11 Lubricants & Glidants
8 Film Formers & Plasticizers
8 Co-Processed Excipients
6 Taste Masking
5 Disintegrants & Superdisintegrants
5 Empty Capsules
4 Vegetarian Capsules
4 Coloring Agents
4 Topical
4 Rheology Modifiers
4 Chewable & Orodispersible Aids
3 API Stability Enhancers
3 Solubilizers
3 Emulsifying Agents
2 Parenteral
1 Surfactant & Foaming Agents

DIGITAL CONTENT

24 News #PharmaBuzz

24 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 27 Regulatory FDF Prices, 19 Annual Reports

1 US Medicaid Prescriptions
27 Regulatory FDF Prices
19 Annual Reports

MARKET PLACE

7 APIs

7 APIs

PATENTS & EXCLUSIVITIES

25 US Patents, 10 Health Canada Patents

25 US Patents
10 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 Others

2 Others

$ API Ref.Price (USD/KG) : 37,749 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

10 All

01 10Bayer Inc.

filter Patent Reset all filters

10 All

01 52485143

02 52936852

filter Product Reset all filters

10 All

01 10Riociguat

filter Dosage Reset all filters

10 All

01 8Tablet

02 2Tablets

filter Exp Date Reset all filters

10 All

01 52023-04-25

02 52030-11-22

Zhejiang Riociguat

Product Main Page

01

Bayer Inc.

Riociguat

Coatings Trends

Not Confirmed

Bayer Inc.

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-04-25

Date Granted : 2011-04-19

Brand Name : ADEMPAS

Patent Number : 2485143

Filing Date : 2003-04-25

Strength per Unit : 0.5 mg

Dosage Form : Tablets

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-04-25

Date Granted : 2011-04-19

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Bayer Inc.

Riociguat

Coatings Trends

Not Confirmed

Bayer Inc.

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-04-25

Date Granted : 2011-04-19

Brand Name : ADEMPAS

Patent Number : 2485143

Filing Date : 2003-04-25

Strength per Unit : 1 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-04-25

Date Granted : 2011-04-19

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Bayer Inc.

Riociguat

Coatings Trends

Not Confirmed

Bayer Inc.

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-04-25

Date Granted : 2011-04-19

Brand Name : ADEMPAS

Patent Number : 2485143

Filing Date : 2003-04-25

Strength per Unit : 1.5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-04-25

Date Granted : 2011-04-19

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Bayer Inc.

Riociguat

Coatings Trends

Not Confirmed

Bayer Inc.

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-04-25

Date Granted : 2011-04-19

Brand Name : ADEMPAS

Patent Number : 2485143

Filing Date : 2003-04-25

Strength per Unit : 2 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-04-25

Date Granted : 2011-04-19

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Bayer Inc.

Riociguat

Coatings Trends

Not Confirmed

Bayer Inc.

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-04-25

Date Granted : 2011-04-19

Brand Name : ADEMPAS

Patent Number : 2485143

Filing Date : 2003-04-25

Strength per Unit : 2.5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-04-25

Date Granted : 2011-04-19

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Bayer Inc.

Riociguat

Coatings Trends

Not Confirmed

Bayer Inc.

Country

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-11-22

Date Granted : 2019-10-29

Brand Name : ADEMPAS

Patent Number : 2936852

Filing Date : 2010-11-22

Strength per Unit : 0.5 mg

Dosage Form : Tablets

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2030-11-22

Date Granted : 2019-10-29

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

07

Bayer Inc.

Riociguat

Coatings Trends

Not Confirmed

Bayer Inc.

Country

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-11-22

Date Granted : 2019-10-29

Brand Name : ADEMPAS

Patent Number : 2936852

Filing Date : 2010-11-22

Strength per Unit : 1 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2030-11-22

Date Granted : 2019-10-29

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

08

Bayer Inc.

Riociguat

Coatings Trends

Not Confirmed

Bayer Inc.

Country

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-11-22

Date Granted : 2019-10-29

Brand Name : ADEMPAS

Patent Number : 2936852

Filing Date : 2010-11-22

Strength per Unit : 1.5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2030-11-22

Date Granted : 2019-10-29

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

09

Bayer Inc.

Riociguat

Coatings Trends

Not Confirmed

Bayer Inc.

Country

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-11-22

Date Granted : 2019-10-29

Brand Name : ADEMPAS

Patent Number : 2936852

Filing Date : 2010-11-22

Strength per Unit : 2 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2030-11-22

Date Granted : 2019-10-29

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

10

Bayer Inc.

Riociguat

Coatings Trends

Not Confirmed

Bayer Inc.

Country

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-11-22

Date Granted : 2019-10-29

Brand Name : ADEMPAS

Patent Number : 2936852

Filing Date : 2010-11-22

Strength per Unit : 2.5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2030-11-22

Date Granted : 2019-10-29

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!